Hypoglycemia was uncommon and largely noticed in individuals concomitantly getting insulin secretagogues or insulin, per the glucose-dependent system of motion. Critical hypoglycemia was scarce, supporting a good threat-benefit profile for both of those diabetic and non-diabetic populations.Continued refinement of formulation and dosing pro… Read More